Dana Farber Cancer Institite — Boston, Massachusetts

Dana Farber Cancer Institite is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institite has participated in 8 clinical trials with 5 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer.

Sponsors: Dana-Farber Cancer Institute, Massachusetts General Hospital, Adrienne G. Waks.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institite?

Dana Farber Cancer Institite has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institite conducted?

Dana Farber Cancer Institite has 8 clinical trials on record, with 5 currently active. Their work covers HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer.

Is Dana Farber Cancer Institite accredited by Crixeo Health?

Yes — Dana Farber Cancer Institite holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dana Farber Cancer Institite?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.